“Marc Beer “

Entrepreneurs Finance People

Marc Beer has 25 years of experience and expertise in the medical field. He has accomplished a lot throughout the time he has been the pharmaceutical industry and has contributed to the development of various healthcare companies. Marc Beer has worked with several prominent companies and has seen them all succeed. He held executive positions for some firms in the medical industry. Before establishing Renovia Inc, Marc Beer had worked with other institutions. He served as a board member of Erytech Pharma and helped out with critical decision making. He also worked at Global Marketing as the Vice President responsible for making announcements on drugs to treat rare diseases. Marc Beer founded ViaCell as biotech institution focuses on development and research of the umbilical cord. He contributed to the growth and expansion of the firms. ViaCell became a public establishment in 2005 and was later acquired by PerkinElmer. ViaCell has grown to a well-performing financial institution through the help of Marc Beer. Marc has created employment opportunities in the firm. Marc Beer went on ahead to establish Renovia Inc in August 2018 with the support of his partners. Marc led the firm into a series B financing that will contribute funds toward the development of a diagnostic of pelvic floor disorder. The firm in the series B financing has raised 42-million-dollars to be used for research and creation of new drugs. Renovia Inc launched their first drug, Leva that got approved by the FDA in April of last year. Marc Beer is delighted to be working with large and prominent medical firms. Marc is gad that these firms all share in Renovia Inc’s vision. Renovia’s vision is to alleviate the lives of women across the globe by providing them with a diagnostic of pelvic floor disease. The vision also focuses on creating effective drugs to treat pelvic floor disorder. Marc Beer believes that through coming together and sharing ideas, they will soon come up with a viable diagnostic. Marc is hoping that the firms will combine ideas and share their innovative technologies to come up with a program that benefits the afflicted. The program is meant to provide knowledge on pelvic floor disorder and to inform individuals on the available treatment methods.Marc Beer would also like to provide the afflicted with treatment methods that are cheap and affordable. The series B financing will consist of several firms including The Longwood Fund. The Longwood Fund is an investment institution that only deals with healthcare companies. The Longwood Fund has previously invested in Renovia. The firms in the series B financing will contribute capital that will be put into the development of four more drugs to diagnose pelvic floor disorder. Learn more: https://patch.com/massachusetts/boston/renovias-marc-beer-raises-42m-treat-womens-health-issues

Leave a Reply

Your email address will not be published. Required fields are marked *